Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) – clinical trial and the SAPS – real world patient-reported outcomes

Objective: The Self-Assessment of Psoriasis Symptoms – Clinical Trials (SAPS-CT) and SAPS – Real World (SAPS-RW) were simultaneously created to assess the experience of plaque psoriasis in two unique contexts. Methods: Qualitative and quantitative research was conducted in four phases namely concept...

Full description

Bibliographic Details
Main Authors: April W. Armstrong, Benjamin Banderas, Catherine Foley, Jonathan Stokes, Murali Sundaram, Alan L. Shields
Format: Article
Language:English
Published: Taylor & Francis Group 2017-08-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2017.1290206
_version_ 1797683733869887488
author April W. Armstrong
Benjamin Banderas
Catherine Foley
Jonathan Stokes
Murali Sundaram
Alan L. Shields
author_facet April W. Armstrong
Benjamin Banderas
Catherine Foley
Jonathan Stokes
Murali Sundaram
Alan L. Shields
author_sort April W. Armstrong
collection DOAJ
description Objective: The Self-Assessment of Psoriasis Symptoms – Clinical Trials (SAPS-CT) and SAPS – Real World (SAPS-RW) were simultaneously created to assess the experience of plaque psoriasis in two unique contexts. Methods: Qualitative and quantitative research was conducted in four phases namely concept elicitation, questionnaire construction, content evaluation and psychometric evaluation. Results: Following concept elicitation, 18 concepts were selected to inform questionnaire construction of the SAPS-CT and SAPS-RW. To accommodate each context of use, the SAPS-CT asks respondents to rate the target symptom ‘at its worst’ in the 24 h prior to assessment, while the SAPS-RW asks respondents to rate the target symptom “on average” in the 7 days prior to assessment. Cognitive debriefing confirmed that patients could comprehend and provide meaningful responses to both versions and, after minor modifications, resulted in 11-item questionnaires administered in an observational study (N = 200). Results from the observational study informed further item reduction (SAPS-RW to six items and SAPS-CT to nine items) and demonstrated that scores from each were reliable (Cronbach’s α > 0.90, test–retest intraclass correlation coefficient >0.70), construct valid and able to differentiate among clinically distinct groups. Conclusion: The SAPS-CT and SAPS-RW are content-valid PRO questionnaires capable of producing psychometrically sound scores when administered chronic to plaque psoriasis patients.
first_indexed 2024-03-12T00:20:07Z
format Article
id doaj.art-49b1aba40f124770a9a45fb3356f6d80
institution Directory Open Access Journal
issn 0954-6634
1471-1753
language English
last_indexed 2024-03-12T00:20:07Z
publishDate 2017-08-01
publisher Taylor & Francis Group
record_format Article
series Journal of Dermatological Treatment
spelling doaj.art-49b1aba40f124770a9a45fb3356f6d802023-09-15T14:08:30ZengTaylor & Francis GroupJournal of Dermatological Treatment0954-66341471-17532017-08-0128650551410.1080/09546634.2017.12902061290206Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) – clinical trial and the SAPS – real world patient-reported outcomesApril W. Armstrong0Benjamin Banderas1Catherine Foley2Jonathan Stokes3Murali Sundaram4Alan L. Shields5University of Southern CaliforniaAdelphi Values USA, Patient-Centered OutcomesAdelphi Values USA, Patient-Centered OutcomesAdelphi Values USA, Patient-Centered OutcomesAbbVie, Health Economics and Outcomes ResearchAdelphi Values USA, Patient-Centered OutcomesObjective: The Self-Assessment of Psoriasis Symptoms – Clinical Trials (SAPS-CT) and SAPS – Real World (SAPS-RW) were simultaneously created to assess the experience of plaque psoriasis in two unique contexts. Methods: Qualitative and quantitative research was conducted in four phases namely concept elicitation, questionnaire construction, content evaluation and psychometric evaluation. Results: Following concept elicitation, 18 concepts were selected to inform questionnaire construction of the SAPS-CT and SAPS-RW. To accommodate each context of use, the SAPS-CT asks respondents to rate the target symptom ‘at its worst’ in the 24 h prior to assessment, while the SAPS-RW asks respondents to rate the target symptom “on average” in the 7 days prior to assessment. Cognitive debriefing confirmed that patients could comprehend and provide meaningful responses to both versions and, after minor modifications, resulted in 11-item questionnaires administered in an observational study (N = 200). Results from the observational study informed further item reduction (SAPS-RW to six items and SAPS-CT to nine items) and demonstrated that scores from each were reliable (Cronbach’s α > 0.90, test–retest intraclass correlation coefficient >0.70), construct valid and able to differentiate among clinically distinct groups. Conclusion: The SAPS-CT and SAPS-RW are content-valid PRO questionnaires capable of producing psychometrically sound scores when administered chronic to plaque psoriasis patients.http://dx.doi.org/10.1080/09546634.2017.1290206prochronic plaque psoriasisinstrumentcontext of usequalitativepsychometric
spellingShingle April W. Armstrong
Benjamin Banderas
Catherine Foley
Jonathan Stokes
Murali Sundaram
Alan L. Shields
Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) – clinical trial and the SAPS – real world patient-reported outcomes
Journal of Dermatological Treatment
pro
chronic plaque psoriasis
instrument
context of use
qualitative
psychometric
title Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) – clinical trial and the SAPS – real world patient-reported outcomes
title_full Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) – clinical trial and the SAPS – real world patient-reported outcomes
title_fullStr Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) – clinical trial and the SAPS – real world patient-reported outcomes
title_full_unstemmed Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) – clinical trial and the SAPS – real world patient-reported outcomes
title_short Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) – clinical trial and the SAPS – real world patient-reported outcomes
title_sort development and psychometric evaluation of the self assessment of psoriasis symptoms saps clinical trial and the saps real world patient reported outcomes
topic pro
chronic plaque psoriasis
instrument
context of use
qualitative
psychometric
url http://dx.doi.org/10.1080/09546634.2017.1290206
work_keys_str_mv AT aprilwarmstrong developmentandpsychometricevaluationoftheselfassessmentofpsoriasissymptomssapsclinicaltrialandthesapsrealworldpatientreportedoutcomes
AT benjaminbanderas developmentandpsychometricevaluationoftheselfassessmentofpsoriasissymptomssapsclinicaltrialandthesapsrealworldpatientreportedoutcomes
AT catherinefoley developmentandpsychometricevaluationoftheselfassessmentofpsoriasissymptomssapsclinicaltrialandthesapsrealworldpatientreportedoutcomes
AT jonathanstokes developmentandpsychometricevaluationoftheselfassessmentofpsoriasissymptomssapsclinicaltrialandthesapsrealworldpatientreportedoutcomes
AT muralisundaram developmentandpsychometricevaluationoftheselfassessmentofpsoriasissymptomssapsclinicaltrialandthesapsrealworldpatientreportedoutcomes
AT alanlshields developmentandpsychometricevaluationoftheselfassessmentofpsoriasissymptomssapsclinicaltrialandthesapsrealworldpatientreportedoutcomes